Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: Secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers

Clinical Therapeutics

Volumn 31, Issue 9, 2009, Pages 1957-1965

  Ferguson, Stuart G ^a,b   Gitchell, Joseph G ^a   Shiffman, Saul ^a,b   Sembower, Mark A ^a  

^a PINNEY ASSOCIATES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

conditional outcomes; nicotine patch; nicotine replacement therapy; smoking cessation

Indexed keywords

CQ; NICOTINE; NICOTINE PATCH; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; HUMAN; LABORATORY TEST; MALE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 72149106177     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.08.029     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR Morb Mortal Wkly Rep 54 (2005) 625-628
2. US Department of Health and Human Services. The Health Consequences of Smoking: What It Means to You (2004), US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Washington, DC
3. Jha P., and Chaloupka F.J. Curbing the Epidemic: Governments and the Economics of Tobacco Control (1999), World Bank, Washington, DC
4. Fiore M.C., Jaén C.R., Baker T.B., et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline (2008), US Dept of Health and Human Services, Public Health Service, Rockville, Md
5. Stead L.F., Perera R., Bullen C., et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 1 (2008) CD000146
6. Shiffman S., Scharf D.M., Shadel W.G., et al. Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 74 (2006) 276-285
7. Wileyto P., Patterson F., Niaura R., et al. Do small lapses predict relapse to smoking behavior under bupropion treatment?. Nicotine Tob Res. 6 (2004) 357-366
8. Durcan M.J., Johnston J.A., White J., et al. Bupropion SR for relapse prevention: A "slips-allowed" analysis. Am J Health Behav. 28 (2004) 456-463
9. Bansal M.A., Cummings K.M., Hyland A., and Giovino G.A. Stopsmoking medications: Who uses them, who misuses them, and who is misinformed about them?. Nicotine Tob Res. 6 Suppl 3 (2004) S303-S310
10. Etter J.F., and Perneger T.V. Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther. 69 (2001) 175-183
11. Shiffman S., Ferguson S.G., Rohay J., and Gitchell J.G. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance. Addiction 103 (2008) 1371-1378
12. Hughes J.R., Gulliver S.B., Fenwick J.W., et al. Smoking cessation among self-quitters. Health Psychol. 11 (1992) 331-334
13. Hughes J.R., Keely J., and Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99 (2004) 29-38
14. Tønnesen P., Paoletti P., Gustavsson G., et al., Collaborative European Anti-Smoking Evaluation, European Respiratory Society. Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. Eur Respir J. 13 (1999) 238-246
15. In: Marlatt G.A., and Gordon J.R. (Eds). Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (1985), Guilford Press, New York, NY
16. Kenford S.L., Fiore M.C., Jorenby D.E., et al. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 271 (1994) 589-594
17. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 266 (1991) 3133-3138
18. Davies H.T., Crombie I.K., and Tavakoli M. When can odds ratios mislead?. BMJ 316 (1998) 989-991
19. Fagerström K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 3 (1978) 235-241
20. Shiffman S., and Paton S.M. Individual differences in smoking: Gender and nicotine addiction. Nicotine Tob Res. 1 Suppl 2 (1999) S153-S157
21. Shiffman S., and Paton S.M. Individual differences in smoking: Gender and nicotine addiction. Nicotine Tob Res. 1 Suppl 2 (1999) S165-S166
22. Shiffman S., Sweeney C.T., Ferguson S.G., et al. Relationship between adherence to daily nicotine patch use and treatment efficacy: Secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-thecounter use in adult smokers. Clin Ther. 30 (2008) 1852-1858
23. GlaxoSmithKline Consumer Healthcare. Nicorette users guide. http://www.fda.gov/MedWatch/SAFETY/2007/Apr_PI/NicoDermCQ_PPI.pdf Accessed June 6, 2009
24. Joseph A.M., Norman S.M., Ferry L.H., et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease [published correction appears in N Engl J Med. 1996;356:2554]. N Engl J Med. 335 (1996) 1792-1798
25. Fagerström K.O., and Hughes J.R. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review. Nicotine Tob Res. 4 Suppl 2 (2002) S73-S79
26. Requesting expansion of availability of nicotine replacement therapy to consumers who use tobacco. http://www.regulations.gov/search/Regs/home.html#docketDetail?R=FDA-2008P-0116 Docket ID: FDA-2008-P-0116. Accessed August 21, 2009
27. Shiffman S., Brockwell S.E., Pillitteri J.L., and Gitchell J.G. Use of smokingcessation treatments in the United States. Am J Prev Med. 34 (2008) 102-111